Champions Oncology
CSBR
32 hedge funds and large institutions have $49.8M invested in Champions Oncology in 2022 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 6 reducing their positions, and 0 closing their positions.
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
7% more funds holding
Funds holding: 30 → 32 (+2)
0.19% more ownership
Funds ownership: 45.82% → 46.01% (+0.19%)
0% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 6
1% less capital invested
Capital invested by funds: $50.4M → $49.8M (-$569K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TAM
Tocqueville Asset Management
New York
|
+$261K |
| 2 |
MAG
Millrace Asset Group
Berwyn,
Pennsylvania
|
+$192K |
| 3 |
Dimensional Fund Advisors
Austin,
Texas
|
+$10.9K |
| 4 |
TCWM
Total Clarity Wealth Management
St. Charles,
Illinois
|
+$7.17K |
| 5 |
BlackRock
New York
|
+$4.29K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$42.8K |
| 2 |
Morgan Stanley
New York
|
-$10.8K |
| 3 |
Millennium Management
New York
|
-$9.58K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$7.82K |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
-$6.68K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
26
UBS Group
Zurich,
Switzerland
| $16K | -$7.82K | -1,022 | -34% |
|
|
TCWM
27
Total Clarity Wealth Management
St. Charles,
Illinois
| $7K | +$7.17K | +937 | New |
|
28
Royal Bank of Canada
Toronto,
Ontario, Canada
| $1K | – | – | – |
|
29
Wells Fargo
San Francisco,
California
| – | +$23 | +3 | +7% |
|
|
TRCT
30
Tower Research Capital (TRC)
New York
| – | +$252 | +33 | New |
|
31
Simplex Trading
Chicago,
Illinois
| – | +$719 | +94 | New |
|
CSBR Hedge Fund Activity: Q2 2022 in Review
32 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Champions Oncology (CSBR) for Q2 2022, worth a combined $49.8M — down 1.1% from $50.4M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new CSBR positions and 0 closed out — a net gain of 3 holders — while 6 added to existing stakes and 6 trimmed.
The largest buyer was Tocqueville Asset Management, adding an estimated $261K. The largest seller was Renaissance Technologies, cutting an estimated $42.8K.
- 32 institutional investors held Champions Oncology (CSBR) as of Q2 2022, up from 30 in Q1 2022.
- Funds reported $49.8M of Champions Oncology stock for Q2 2022, down 1.1% quarter-over-quarter.
- 3 funds opened new Champions Oncology positions in Q2 2022 and 0 closed out, a net change of +3 holders.
- The largest Champions Oncology buyer in Q2 2022 was Tocqueville Asset Management, an estimated $261K added.
- The largest Champions Oncology seller in Q2 2022 was Renaissance Technologies, an estimated $42.8K sold.
Based on aggregated 13F filings for Q2 2022.